| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Zivo Bioscience, Inc. (ZIVO) has 4 insiders with recent SEC Form 4 filings, including 17 buys and 0 sells. ZIVO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 577.9K | $2.13M | - | |
| 10% | 517.5K | $1.91M | - | |
| 10% | 452.9K | $1.67M | - | |
| Dir | 1.2K | $4.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2022 | Cornell Alison A | Director | Buy | 12,000 | $3.00 | $36,000.00 | +80.0% | |
| Sep 14, 2022 | Maggiore Christopher D. | Director, 10% Owner | Buy | 7,200 | $3.53 | $25,447.52 | +0.4% | |
| Feb 11, 2022 | Maggiore Christopher D. | Director, 10% Owner | Buy | 91,334 | $3.72 | $340,097.73 | +4.1% | |
| Jan 27, 2022 | Payne John Bernard | Director | Buy | 9,168 | $2.50 | $22,920.00 | +96.8% | |
| Jan 11, 2022 | Maggiore Christopher D. | Director, 10% Owner | Buy | 7,560 | $2.64 | $19,956.13 | +1.1% | |
| Jun 2, 2021 | Strome Mark E | 10% Owner | Buy | 40,000 | $4.99 | $199,600.00 | +24.4% | |
| Jun 2, 2021 | Masterson Nola E | Director | Buy | 400 | $4.99 | $1,996.00 | +8.9% | |
| Jun 2, 2021 | Cornell Alison A | Director | Buy | 15,000 | $4.99 | $74,850.00 | New | |
| Jun 2, 2021 | Maggiore Christopher D. | Director, 10% Owner | Buy | 100,000 | $4.99 | $499,000.00 | +16.6% | |
| Jan 22, 2020 | Maggiore Christopher D. | Director, 10% Owner | Buy | 65,000 | $0.16 | $10,160.00 | - |